Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
Nasopharyngeal cancer (NPC), endemic in Southeast Asia, lacks effective diagnostic and therapeutic strategies. Even in high-income countries the 5-year survival rate for stage IV NPC is less than 40%. Here we report high somatostatin receptor 2 (SSTR2) expression in multiple clinical cohorts compris...
Egile Nagusiak: | Lechner, M, Schartinger, VH, Steele, C, Philpott, M, Nibhani, R, Koller, J, Wells, G, Oppermann, U, Et al. |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Nature Research
2021
|
Antzeko izenburuak
-
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
nork: Matt Lechner, et al.
Argitaratua: (2021-01-01) -
The role of Epstein–Barr virus in nasopharyngeal carcinoma
nork: Zhi Yi Su, et al.
Argitaratua: (2023-02-01) -
Link of Nasopharyngeal Carcinoma and Epstein-Barr Virus
nork: Sugiyanto Sugiyanto, et al.
Argitaratua: (2018-10-01) -
Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
nork: Pok Man Hau, et al.
Argitaratua: (2020-05-01) -
Patterns of failure and prognosis in nasopharyngeal carcinoma according to Epstein-Barr virus DNA status
nork: Lin-Feng Guo, et al.
Argitaratua: (2025-02-01)